Evidence map›Paper›PMID 33544252›Full record

ReviewTopics in current chemistry (Cham)2021

Merging Boron with Nitrogen-Oxygen Bonds: A Review on BON Heterocycles.

Ivan S Golovanov, Alexey Yu Sukhorukov

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. 1,4,6,10-Tetraazaadamantanes (TAADs) withBeilstein journal of organic chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ivan S GolovanovLaboratory of Organic and Metal-Organic Nitrogen-Oxygen Systems, N. D. Zelinsky Institute of Organic Chemistry, Leninsky prospect, 47, 119991, Moscow, Russia. cell-25@yandex.ru.ORCID https://orcid.org/0000-0001-7219-2409
Alexey Yu SukhorukovLaboratory of Organic and Metal-Organic Nitrogen-Oxygen Systems, N. D. Zelinsky Institute of Organic Chemistry, Leninsky prospect, 47, 119991, Moscow, Russia. sukhorukov@ioc.ac.ru.ORCID http://orcid.org/0000-0003-4413-9453

Funding

Российский Фонд Фундаментальных Исследований (РФФИ) 20-33-70188
6 · The paper itself

Abstract

Cyclic boronate esters play important roles in organic synthesis, pharmacology, supramolecular chemistry and materials science owing to their stability in air and versatile reactivity. Most of these compounds contain a B-O-C linkage with an alkoxy- or carboxylate group bound to the boron atom (e.g. boronate-diol esters, MIDA boronates). Boron chelates comprising a B-O-N motif (BON heterocycles) are much less explored, although first representatives of this class were prepared in the early 1960s. In recent years, there has been a growing interest in BON heterocycles as new chemotypes for drug design. The exocyclic B-O-N linkage, which is readily formed under mild conditions, shows surprising hydrolytic and thermal resistance. This allows the formation of BON heterocycles to be used as click-type reactions for the preparation of bioconjugates and functionally modified polymers. We believe that BON heterocycles are promising yet underrated organoboron derivatives. This review summarizes the scattered information about known types of BON heterocycles, including their synthesis, reactivity and structural data. Available applications of BON heterocycles in materials science and medicinal chemistry, along with their prospects, are also discussed. The bibliography contains 289 references.

Indexed as

BoronHeterocyclic CompoundsMolecular StructureNitrogenOxygenBoronHeterocyclic CompoundsNitrogenOxygenBoron heterocyclesBoronic acidsHydroxylaminesOrganoboron derivatives

Identifiers

PMID33544252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.